文献速递神经肌肉病

肌萎缩侧索硬化症的终生风险与遗传力

Lifetime Risk and Heritability of Amyotrophic Lateral Sclerosis.
PubMed 文献 · JAMA Neurol · 2019-01-01

该前瞻性人群为基础的亲子遗传力研究纳入1117例爱尔兰ALS患者,发现一级亲属终生风险为1.4%,高于一般人群的0.3%;总体终生遗传力为52.3%,无已知遗传风险者为36.9%,母女配对遗传力最高(66.2%)。

要点

  • ALS一级亲属终生风险1.4%,显著高于一般人群0.3%。
  • 总体终生遗传力52.3%,无已知遗传风险者36.9%。
  • 母女配对遗传力最高66.2%,提示性别介导效应。

核心结论

  • 高达50%的ALS变异有遗传基础,C9orf72变异是遗传力的重要决定因素。
  • 无已知遗传基础ALS患者的一级亲属风险仍高于一般人群。
  • 母女配对遗传力更高提示既往未识别的性别介导效应。

研究设计与样本

  • 前瞻性人群为基础亲子遗传力研究,2008年1月1日至2017年12月31日。
  • 从爱尔兰ALS登记处识别1123例经El Escorial标准诊断的incident ALS病例。

主要发现

  • 研究期间识别32对亲子ALS配对。
  • 总体终生遗传力52.3%(95%CI 42.9%-61.7%),无已知遗传风险者36.9%(95%CI 19.8%-53.9%)。
  • 母女配对遗传力最高66.2%(95%CI 58.5%-73.9%)。

临床怎么用

  • 对ALS患者一级亲属进行风险告知时,可参考终生风险1.4%及遗传力数据。
  • 无已知遗传基础者一级亲属仍需关注风险升高。
  • 母女配对遗传力更高提示需关注性别相关遗传咨询。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Heritability describes the proportion of variance in the risk of developing a condition that is explained by genetic factors. Although amyotrophic lateral sclerosis (ALS) is known to have a complex genetic origin, disease heritability remains unclear. OBJECTIVES: To determine the extent of ALS heritability and assess the association of sex with disease transmission. DESIGN, SETTING, AND PARTICIPANTS: A prospective population-based parent-offspring heritability study was conducted from January 1, 2008, to December 31, 2017 to assess ALS heritability, and was the first study to assess heritability in the context of known gene mutations of large effect. A total of 1123 incident cases of ALS, diagnosed according to the El Escorial criteria and recorded on the Irish ALS register, were identified. Ninety-two individuals were excluded (non-Irish parental origin [n = 86] and familial ALS [n = 6]), and 1117 patients were included in the final analysis. MAIN OUTCOMES AND MEASURES: Annual age-specific and sex-specific standardized ALS incidence and mortality-adjusted lifetime risk were determined. Sex-specific heritability estimates were calculated for the overall study cohort, for those known to carry the C9orf72 (OMIM 614260) variant, and for those with no known genetic risk. RESULTS: A total of 32 parent-child ALS dyads were identified during the study period. Affected offspring were younger at the onset of disease (mean age, 52.0 years; 95% CI, 48.8-55.3 years) compared with their parents (mean age, 69.6 years; 95% CI, 62.4-76.9 years; P = .008). Lifetime risk of developing ALS in first-degree relatives of individuals with ALS was increased compared with the general population (1.4% [32 of 2234] vs 0.3% [2.6 of 1000]; P < .001). Mean lifetime heritability of ALS for the overall study cohort was 52.3% (95% CI, 42.9%-61.7%) and 36.9% (95% CI, 19.8%-53.9%) for those with no known genetic risk. Heritability estimates were highest in mother-daughter pairings (66.2%; 95% CI, 58.5%-73.9%). CONCLUSIONS AND RELEVANCE: This population-based study confirms that up to 50% of variance in ALS has a genetic basis, and that the presence of the C9orf72 variant is an important determinant of heritability. First-degree relatives of individuals with ALS without a known genetic basis remain at increased risk of developing ALS compared with the general population. A higher heritability estimate in mother-daughter pairings points to a sex-mediated effect that has been previously unrecognized.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Ryan M, Heverin M, McLaughlin RL, et al. Lifetime Risk and Heritability of Amyotrophic Lateral Sclerosis. JAMA Neurol. 2019. PMID: 31329211. doi:10.1001/jamaneurol.2019.2044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。